GlassScriptPhysician profile
Susan D Wegrzyn
NPI 1518086206
$2,323.34
in general payments reported to CMS, 2019-2025
16 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $232 · 2023: $731 · 2024: $560 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $920.04 | 2021-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $389.87 | 2022-2025 | Octrode, Eterna, Proclaim |
| Abbvie INC. | $235.54 | 2022-2025 | |
| Scilex Pharmaceuticals INC. | $156.04 | 2021-2024 | |
| Nevro Corp. | $146.81 | 2021-2024 | Senza |
| Pfizer INC. | $114.71 | 2023-2024 | |
| Lilly USA, LLC | $72.84 | 2024 | Zepbound, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $65.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.25 | 2024-2025 | Relistor |
| Spr Therapeutics, INC | $39.13 | 2024 | Sprint Pns System |
| Kowa Pharmaceuticals America, INC. | $34.07 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $27.41 | 2021 | |
| Protega Pharmaceutials INC | $22.42 | 2023 | Roxybond |
| Almatica Pharma LLC | $22.15 | 2023 | Gralise |
| Hikma Pharmaceuticals USA | $16.31 | 2023 | Kloxxado |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $14.67 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Wegrzyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.